Aromatic ring oxidation of N-n-butylamphetamine is enhanced in the rat by prior treatment with quinidine

Res Commun Chem Pathol Pharmacol. 1991 Oct;74(1):15-24.

Abstract

Prior administration of quinidine is known to reduce aromatic oxidation of amphetamine and its analog methoxyphenamine by inhibiting the cytochrome P450IID6 results in isozyme. In contrast, it is now shown that prior administration of quinidine results in a significant increase in the aromatic oxidation of N-n-butylamphetamine in rat, suggesting that the P450IID6 isozyme is not involved in this metabolic reaction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chromatography, Gas
  • Cytochrome P-450 CYP2D6
  • Cytochrome P-450 Enzyme System / metabolism
  • Dextroamphetamine / analogs & derivatives*
  • Dextroamphetamine / analysis
  • Dextroamphetamine / metabolism
  • Male
  • Mixed Function Oxygenases / metabolism
  • Oxidation-Reduction
  • Quinidine / pharmacology*
  • Rats
  • Rats, Inbred Strains

Substances

  • d-N-butylamphetamine
  • Cytochrome P-450 Enzyme System
  • Mixed Function Oxygenases
  • Cytochrome P-450 CYP2D6
  • Quinidine
  • Dextroamphetamine